Stable Isotope Labeled Compounds Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others), By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others), By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others), By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others), By Method (Chemical, Cell-culturing), By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others), By Region, Competition, Forecast & Opportunities, 2028

December 2022 | 116 pages | ID: SEE2A6D0B9E1EN
TechSci Research

Abstracts

The global stable isotope labeled compounds is expected to grow at a significant rate during the forecast period, 2024-2028. The increasing incidence and prevalence of cancer coupled with growing research and development activities in proteomics are expected to augment the growth of the market. According to the World Health Organization (WHO), Cancer is a major factor for the cause of death across the world, accounting for approximately 10 million deaths in 2020, or about one in six deaths. The most common cancers are lung, breast, colon and rectum and prostate cancers. Stable isotope labeled compounds are used to check the isotope pathway during a chemical metabolism or to detect any isotopic presence in the cells. Thus, they are generally used in biomedical research and the R&D sector, which, in turn, propel the growth of the market. Besides, the growing investments in research and development programs by the biotechnology and pharmaceutical companies along with surge in demand for new effective therapeutics and diagnosis are anticipated to facilitate the growth of the market.

However, the inability to buy stable isotope labeled compounds due to high cost is expected to slow down the growth of the market. Also, lack of skilled professionals for conducting research activities is anticipated to hinder the growth of the market in upcoming years.

The global stable isotope labeled compounds market is segmented into compounds, application, substances, indication, method, end-user, company, and region. The end-user segment is further fragmented into pharmaceutical and biotechnology companies, academic institute, and others. Out of which, pharmaceutical and biotechnology companies segment is expected to be the fastest growing segment in the coming years. This is ascribed to the increasing research & development spending, and growing use of stable isotope-labeled compounds in R&D in the pharmaceutical and biotechnology companies.

Based on region, global stable isotope labeled compounds market is segmented into Asia-Pacific, Europe, North America, South America, and Middle East & Africa. As of 2022, North America is expected to dominate the stable isotope-labeled compounds market in the forecast period. This is attributed to the presence of various stable isotope-based research companies, along with growing support for the sector from the Isotope Production and Distribution Program Fund.

Major players of the global stable isotope labeled compounds market include PerkinElmer Inc., Merck KGaA, 3M, Cambridge Isotope Laboratories, Inc., JSC Isotope., Creative Proteomics., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Sciences International, and Nippon Sanso Holdings Corporation.

Objective of the Study:

• To analyze and forecast the market size of global stable isotope labeled compounds market.
• To classify and forecast global stable isotope labeled compounds market based on compounds, application, substances, indication, method, end-user, region and company.
• To identify drivers and challenges for global stable isotope labeled compounds market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global stable isotope labeled compounds market.
• To conduct pricing analysis for global stable isotope labeled compounds market.
• To identify and analyze the profile of leading players operating in global stable isotope labeled compounds market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global stable isotope labeled compounds market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Stable isotope labeled compounds market players, suppliers, distributors and other stakeholders
• Biotechnology and pharma companies
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to stable isotope labeled compounds
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global stable isotope labeled compounds market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Stable Isotope Labeled Compounds Market, By Compounds:
• Carbon (13C)
• Nitrogen(15N)
• Deuterium
• Oxygen(18O)
• Others
• Stable Isotope Labeled Compounds Market, By Application:
• Diagnosis
• Drug Discovery
• Imaging
• Sterilization
• Others
• Stable Isotope Labeled Compounds Market, By Substances:
• Nucleic Acids
• Amino Acids
• Drugs/Metabolites
• Fatty Acids/Lipids
• NMR Solvents
• Others
• Stable Isotope Labeled Compounds Market, By Indication:
• Cardiology
• Neurology
• Inflammation
• Metabolic disease
• Others
• Stable Isotope Labeled Compounds Market, By Method:
• Chemical
• Cell-culturing
• Stable Isotope Labeled Compounds Market, By End-User:
• Pharmaceutical and Biotechnology Companies
• Academic Institute
• Others
• Stable Isotope Labeled Compounds Market, By Region:
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• North America
• United States
• Mexico
• Canada
• South America
• Brazil
• Argentina
• Colombia
• Middle east & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global stable isotope labeled compounds market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL STABLE ISOTOPES LABELED COMPOUNDS MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value & Volume
5.2. Market Share & Forecast
  5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids. NMR Solvents and Others)
  5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
  5.2.5. By Method (Chemical, Cell-culturing)
  5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  5.2.7. By Company (2022)
  5.2.8. By Region
5.3. Market Map
  5.3.1. By Compounds
  5.3.2. By Application
  5.3.3. By Substances
  5.3.4. By Indication
  5.3.5. By Method
  5.3.6. By End User

6. ASIA-PACIFIC STABLE ISOTOPES LABELED COMPOUNDS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value & Volume
6.2. Market Share & Forecast
  6.2.1. By Compounds
  6.2.2. By Application
  6.2.3. By Substances
  6.2.4. By Indication
  6.2.5. By Method
  6.2.6. By End-User
  6.2.7. By Country
6.3. Asia-Pacific: Country Analysis
  6.3.1. China Stable Isotopes Labeled Compounds Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Compounds
      6.3.1.2.2. By Application
      6.3.1.2.3. By Substances
      6.3.1.2.4. By Indication
      6.3.1.2.5. By Method
      6.3.1.2.6. By End-User
  6.3.2. India Stable Isotopes Labeled Compounds Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Compounds
      6.3.2.2.2. By Application
      6.3.2.2.3. By Substances
      6.3.2.2.4. By Indication
      6.3.2.2.5. By Method
      6.3.2.2.6. By End-User
  6.3.3. Japan Stable Isotopes Labeled Compounds Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Compounds
      6.3.3.2.2. By Application
      6.3.3.2.3. By Substances
      6.3.3.2.4. By Indication
      6.3.3.2.5. By Method
      6.3.3.2.6. By End-User
  6.3.4. South Korea Stable Isotopes Labeled Compounds Market Outlook
    6.3.4.1. Market Size & Forecast
      6.3.4.1.1. By Value
    6.3.4.2. Market Share & Forecast
      6.3.4.2.1. By Compounds
      6.3.4.2.2. By Application
      6.3.4.2.3. By Substances
      6.3.4.2.4. By Indication
      6.3.4.2.5. By Method
      6.3.4.2.6. By End-User
  6.3.5. Australia Stable Isotopes Labeled Compounds Market Outlook
    6.3.5.1. Market Size & Forecast
      6.3.5.1.1. By Value
    6.3.5.2. Market Share & Forecast
      6.3.5.2.1. By Compounds
      6.3.5.2.2. By Application
      6.3.5.2.3. By Substances
      6.3.5.2.4. By Indication
      6.3.5.2.5. By Method
      6.3.5.2.6. By End-User

7. EUROPE STABLE ISOTOPES LABELED COMPOUNDS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value & Volume
7.2. Market Share & Forecast
  7.2.1. By Compounds
  7.2.2. By Application
  7.2.3. By Substances
  7.2.4. By Indication
  7.2.5. By Method
  7.2.6. By End-User
  7.2.7. By Country
7.3. Europe: Country Analysis
  7.3.1. France Stable Isotopes Labeled Compounds Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Compounds
      7.3.1.2.3. By Application
      7.3.1.2.4. By Substances
      7.3.1.2.5. By Indication
      7.3.1.2.6. By Method
      7.3.1.2.7. By End-User
  7.3.2. Germany Stable Isotopes Labeled Compounds Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Compounds
      7.3.2.2.2. By Application
      7.3.2.2.3. By Substances
      7.3.2.2.4. By Indication
      7.3.2.2.5. By Method
      7.3.2.2.6. By End-User
  7.3.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Compounds
      7.3.3.2.2. By Application
      7.3.3.2.3. By Substances
      7.3.3.2.4. By Indication
      7.3.3.2.5. By Method
      7.3.3.2.6. By End-User
  7.3.4. Italy Stable Isotopes Labeled Compounds Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Compounds
      7.3.4.2.2. By Application
      7.3.4.2.3. By Substances
      7.3.4.2.4. By Indication
      7.3.4.2.5. By Method
      7.3.4.2.6. By End-User
  7.3.5. Spain Stable Isotopes Labeled Compounds Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Compounds
      7.3.5.2.2. By Application
      7.3.5.2.3. By Substances
      7.3.5.2.4. By Indication
      7.3.5.2.5. By Method
      7.3.5.2.6. By End-User

8. NORTH AMERICA STABLE ISOTOPES LABELED COMPOUNDS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value & Volume
8.2. Market Share & Forecast
  8.2.1. By Compounds
  8.2.2. By Application
  8.2.3. By Substances
  8.2.4. By Indication
  8.2.5. By Method
  8.2.6. By End-User
  8.2.7. By Country
8.3. North America: Country Analysis
  8.3.1. United States Stable Isotopes Labeled Compounds Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Compounds
      8.3.1.2.2. By Application
      8.3.1.2.3. By Substances
      8.3.1.2.4. By Indication
      8.3.1.2.5. By Method
      8.3.1.2.6. By End-User
  8.3.2. Mexico Stable Isotopes Labeled Compounds Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Compounds
      8.3.2.2.2. By Application
      8.3.2.2.3. By Substances
      8.3.2.2.4. By Indication
      8.3.2.2.5. By Method
      8.3.2.2.6. By End-User
  8.3.3. Canada Stable Isotopes Labeled Compounds Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Compounds
      8.3.3.2.2. By Application
      8.3.3.2.3. By Substances
      8.3.3.2.4. By Indication
      8.3.3.2.5. By Method
      8.3.3.2.6. By End-User

9. SOUTH AMERICA STABLE ISOTOPES LABELED COMPOUNDS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value & Volume
9.2. Market Share & Forecast
  9.2.1. By Compounds
  9.2.2. By Application
  9.2.3. By Substances
  9.2.4. By Indication
  9.2.5. By Method
  9.2.6. By End-User
  9.2.7. By Country
9.3. South America: Country Analysis
  9.3.1. Brazil Stable Isotopes Labeled Compounds Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Compounds
      9.3.1.2.2. By Application
      9.3.1.2.3. By Substances
      9.3.1.2.4. By Indication
      9.3.1.2.5. By Method
      9.3.1.2.6. By End-User
  9.3.2. Argentina Stable Isotopes Labeled Compounds Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Compounds
      9.3.2.2.2. By Application
      9.3.2.2.3. By Substances
      9.3.2.2.4. By Indication
      9.3.2.2.5. By Method
      9.3.2.2.6. By End-User
  9.3.3. Colombia Stable Isotopes Labeled Compounds Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Compounds
      9.3.3.2.2. By Application
      9.3.3.2.3. By Substances
      9.3.3.2.4. By Indication
      9.3.3.2.5. By Method
      9.3.3.2.6. By End-User

10. MIDDLE EAST AND AFRICA STABLE ISOTOPES LABELED COMPOUNDS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value & Volume
10.2. Market Share & Forecast
  10.2.1. By Compounds
  10.2.2. By Application
  10.2.3. By Substances
  10.2.4. By Indication
  10.2.5. By Method
  10.2.6. By End-User
  10.2.7. By Country
10.3. MEA: Country Analysis
  10.3.1. South Africa Stable Isotopes Labeled Compounds Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Compounds
      10.3.1.2.2. By Application
      10.3.1.2.3. By Substances
      10.3.1.2.4. By Indication
      10.3.1.2.5. By Method
      10.3.1.2.6. By End-User
  10.3.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Compounds
      10.3.2.2.2. By Application
      10.3.2.2.3. By Substances
      10.3.2.2.4. By Indication
      10.3.2.2.5. By Method
      10.3.2.2.6. By End-User
  10.3.3. UAE Stable Isotopes Labeled Compounds Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Compounds
      10.3.3.2.2. By Application
      10.3.3.2.3. By Substances
      10.3.3.2.4. By Indication
      10.3.3.2.5. By Method
      10.3.3.2.6. By End-User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Mergers & Acquisitions
12.2. Product Launches
12.3. Technological Advancements

13. COMPETITIVE LANDSCAPE

13.1. Competition Outlook
13.2. Company Profiles
  13.2.1. Company Details
  13.2.2. Products & Services
  13.2.3. Financials (As Reported)
  13.2.4. Key Market Focus Area & Geographical Presence
  13.2.5. Recent Developments
  13.2.6. Key Management Personnel
    13.2.6.1. PerkinElmer Inc.
    13.2.6.2. Merck KGaA
    13.2.6.3. 3M Company
    13.2.6.4. Cambridge Isotope Laboratories, Inc.
    13.2.6.5. JSC Isotope.
    13.2.6.6. Creative Proteomics.
    13.2.6.7. Medical Isotopes, Inc.
    13.2.6.8. Omicron Biochemicals, Inc.
    13.2.6.9. Trace Sciences International
    13.2.6.10. Nippon Sanso Holdings Corporation

14. STRATEGIC RECOMMENDATIONS